Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Disruption of proteostasis causes IRE1 mediated reprogramming of alveolar epithelial cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 17, 2022
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases.
Journal: Journal of medicinal chemistry
Published: October 28, 2021
Tracking and Assessing Oil Spill Toxicity to Aquatic Organisms: A Novel Approach.
Journal: Environmental toxicology and chemistry
Published: September 11, 2020
The Selective Peroxisome Proliferator-Activated Receptor Gamma Modulator CHS-131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis.
Journal: Hepatology communications
Published: March 18, 2020
Evaluating the efficacy of DGT to quantify copper in stormwater at end-of-pipe.
Journal: Chemosphere
Published: April 30, 2019
Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes.
Journal: Diabetes care
Published: May 03, 2017
Model-based Meta-Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis.
Journal: CPT: pharmacometrics & systems pharmacology
Published: February 07, 2017
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
Journal: Chest
Published: September 13, 2016
Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes.
Journal: Scientific reports
Published: October 08, 2015
Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.
Journal: Journal of translational medicine
Published: February 27, 2015
Last Updated: 09/26/2026